These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 34480112)
1. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2. Zhang YL; Zhang WX; Yan JQ; Tang YL; Jia WJ; Xu ZW; Xu MJ; Chattipakorn N; Wang Y; Feng JP; Liu ZG; Liang G Acta Pharmacol Sin; 2022 Jan; 43(1):76-85. PubMed ID: 34480112 [TBL] [Abstract][Full Text] [Related]
2. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury. Zhang Y; Xu T; Wu B; Chen H; Pan Z; Huang Y; Mei L; Dai Y; Liu X; Shan X; Liang G J Cell Mol Med; 2017 Apr; 21(4):746-757. PubMed ID: 27860279 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury. Chen H; Zhang Y; Zhang W; Liu H; Sun C; Zhang B; Bai B; Wu D; Xiao Z; Lum H; Zhou J; Chen R; Liang G Phytomedicine; 2019 Oct; 63():152997. PubMed ID: 31254764 [TBL] [Abstract][Full Text] [Related]
4. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2. Wu P; Yan H; Qi J; Jia W; Zhang W; Yao D; Ding C; Zhang Y; Chen M; Cai X Drug Dev Res; 2020 Feb; 81(1):85-92. PubMed ID: 31693211 [TBL] [Abstract][Full Text] [Related]
5. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury. Zhang Y; Wu J; Ying S; Chen G; Wu B; Xu T; Liu Z; Liu X; Huang L; Shan X; Dai Y; Liang G Sci Rep; 2016 Apr; 6():25130. PubMed ID: 27118147 [TBL] [Abstract][Full Text] [Related]
6. Radix Glycyrrhizae extract and licochalcone a exert an anti-inflammatory action by direct suppression of toll like receptor 4. Cai M; Xu YC; Deng B; Chen JB; Chen TF; Zeng KF; Chen S; Deng SH; Tan ZB; Ding WJ; Zhang SW; Liu B; Zhang JZ J Ethnopharmacol; 2023 Feb; 302(Pt A):115869. PubMed ID: 36309116 [TBL] [Abstract][Full Text] [Related]
7. Discovery of caffeic acid phenethyl ester derivatives as novel myeloid differentiation protein 2 inhibitors for treatment of acute lung injury. Chen L; Jin Y; Chen H; Sun C; Fu W; Zheng L; Lu M; Chen P; Chen G; Zhang Y; Liu Z; Wang Y; Song Z; Liang G Eur J Med Chem; 2018 Jan; 143():361-375. PubMed ID: 29202400 [TBL] [Abstract][Full Text] [Related]
8. Piperlongumine mitigates LPS-induced inflammation and lung injury via targeting MD2/TLR4. Tang Y; Zhang W; Wu L; Bai B; Zheng B; Li M; Tang Y; Zhu X; Zhang Y; Wang Y; Zhang B Biochem Biophys Res Commun; 2023 Jan; 642():118-127. PubMed ID: 36566563 [TBL] [Abstract][Full Text] [Related]
9. Optimization and anti-inflammatory evaluation of methyl gallate derivatives as a myeloid differentiation protein 2 inhibitor. Qiu Y; Xiao Z; Wang Y; Zhang D; Zhang W; Wang G; Chen W; Liang G; Li X; Zhang Y; Liu Z Bioorg Med Chem; 2019 Oct; 27(20):115049. PubMed ID: 31466835 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2. Ye J; Guan M; Lu Y; Zhang D; Li C; Li Y; Zhou C Eur J Pharmacol; 2019 Jun; 852():151-158. PubMed ID: 30807747 [TBL] [Abstract][Full Text] [Related]
11. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2. Yang L; Luo W; Zhang Q; Hong S; Wang Y; Samorodov AV; Chattipakorn N; Pavlov VN; Liang G Phytomedicine; 2021 Dec; 93():153785. PubMed ID: 34638032 [TBL] [Abstract][Full Text] [Related]
12. Licochalcone A protects against LPS-induced inflammation and acute lung injury by directly binding with myeloid differentiation factor 2 (MD2). Zhu W; Wang M; Jin L; Yang B; Bai B; Mutsinze RN; Zuo W; Chattipakorn N; Huh JY; Liang G; Wang Y Br J Pharmacol; 2023 Apr; 180(8):1114-1131. PubMed ID: 36480410 [TBL] [Abstract][Full Text] [Related]
13. Shikonin inhibits myeloid differentiation protein 2 to prevent LPS-induced acute lung injury. Zhang Y; Xu T; Pan Z; Ge X; Sun C; Lu C; Chen H; Xiao Z; Zhang B; Dai Y; Liang G Br J Pharmacol; 2018 Mar; 175(5):840-854. PubMed ID: 29243243 [TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation. Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218 [TBL] [Abstract][Full Text] [Related]
15. Discovery of new MD2-targeted anti-inflammatory compounds for the treatment of sepsis and acute lung injury. Chen G; Xiao B; Chen L; Bai B; Zhang Y; Xu Z; Fu L; Liu Z; Li X; Zhao Y; Liang G Eur J Med Chem; 2017 Oct; 139():726-740. PubMed ID: 28858767 [TBL] [Abstract][Full Text] [Related]
16. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2. Luo W; Yang LB; Qian CC; Ma B; Manjengwa GM; Miao XM; Wang J; Hu CH; Jin B; Zhang LX; Zheng C; Liang G; Wang Y Acta Pharmacol Sin; 2022 Jul; 43(7):1758-1768. PubMed ID: 34737421 [TBL] [Abstract][Full Text] [Related]
17. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2. Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641 [TBL] [Abstract][Full Text] [Related]
18. Cyclic-di-GMP induces inflammation and acute lung injury through direct binding to MD2. Qian C; Zhu W; Wang J; Wang Z; Tang W; Liu X; Jin B; Xu Y; Zhang Y; Liang G; Wang Y Clin Transl Med; 2024 Aug; 14(8):e1744. PubMed ID: 39166890 [TBL] [Abstract][Full Text] [Related]
19. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways. Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117 [TBL] [Abstract][Full Text] [Related]
20. Inhibition Of JNK Phosphorylation By Curcumin Analog C66 Protects LPS-Induced Acute Lung Injury. Xiao Z; Xu F; Zhu X; Bai B; Guo L; Liang G; Shan X; Zhang Y; Zhao Y; Zhang B Drug Des Devel Ther; 2019; 13():4161-4171. PubMed ID: 31849448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]